NCT06230445RecruitingPhase 3
Effects of Digital Therapeutic in Whole Process Management of Lung Cancer
A Phase 3, Randomized, Open-label Trial of Digital Therapeutic vs Regular Follow-up in Whole Process Management of Lung Cancer
Source: ClinicalTrials.gov · Last updated 26 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This trial will randomize patients into two groups, the treatment group will use the digital therapeutic application named 'UHealth' for the whole process management and the control group will use regular follow-up. The trial aims to look into the difference between quality of life, anxiety/depression index, emergency treatment times, hospital admission rate, treatment compliance, OS, DFS and follow-up cost.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 900 (estimated)
- First submitted
- 31 Aug 2023
- Start date
- 1 Jun 2023
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- Sun Yat-sen University
- Diseases
- Lung cancer
- NCT number
- NCT06230445
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 900
- From 1 Jun 2023 to the primary completion date, 1 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients have disease progression in the screening period;
- Patients with dementia, schizophrenia or other psychological diseases that may affect the cognitive behavior;
- Other medical, mental or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or understand the patient information;
Other
- Patients with symptomatic brain metastasis;
- Women who are pregnant or in the period of breastfeeding.
Who the study is looking for
- Patients with histologically or cytologically confirmed lung cancer;
- Patients have received surgery, neoadjuvant therapy, adjuvant therapy, radiotherapy or other chemotherapy, such as cytotoxic chemotherapy, targeted therapy and immunotherapy;
- ECOG (Performance status) 0-1;
- Patients aged \> 18 years and \< 70 years;
- The patients themselves or their family members are familiar with mobile and internet;
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sun Yat-sen University Cancer Center Coordinator of this site? Confirm its status | Guangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.